KR920021142A - 유선염 치료법 - Google Patents
유선염 치료법 Download PDFInfo
- Publication number
- KR920021142A KR920021142A KR1019920007370A KR920007370A KR920021142A KR 920021142 A KR920021142 A KR 920021142A KR 1019920007370 A KR1019920007370 A KR 1019920007370A KR 920007370 A KR920007370 A KR 920007370A KR 920021142 A KR920021142 A KR 920021142A
- Authority
- KR
- South Korea
- Prior art keywords
- halo
- alkyl
- hydroxy
- medicament
- substituents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pregnancy & Childbirth (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Fodder In General (AREA)
- Medicinal Preparation (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (5)
- 임신한 암컷 반추동무의 유선염을 치료 또는 예방하기에 유용한 피하투여용 약제의 제조에 있어서의 하기 일반식(I)의 호합물 또는 그의 산 부가염의 용도.상기식에서, R은 일반식(여기서, 질소원자는 5내지 16개의 고리 원자를 함유하는 모노사이클릭고리, 또는 8내지 20개의 고리원자를 함유하는 비사이클릭 또는 트리사이클릭 고리 시스템중에서 선택된 다른 카보사이클릭 고리 시스템의 일부이다)의 포화 또는 불포화 2급 아미노 그룹; 또는 하나 이상의 탄소원자가 C1-C4-알킬, C2-C4-알케닐, C2-C4-알키닐, C1-C4-알콕시, C1-C4-알콕시카보닐, 하이드록실, C1-C4-알카노일옥시, 할로, 할로-C1-C4-알킬,-N(C1-C4-알킬)2, N-(CH2)m,(C1-C4-알킬)2,(CH2)m, 시아노, 에틸렌디옥시, 벤질, 페닐, 또는 니트로, 할로, C1-C4-알킬, C1-C4-알콕시, 하이드록시, 아미노 또는 모노-또는 디-(C1-C4-알킬)아미노중에서 선택된 1내지 3개의 치환체로 치환된 페닐로 치환된 상기 아미노 그룹이고, m은 4내지 7의 정수이며,R1은또는이고,R2는 수소; C1-C5-알카노일, 또는 1내지 3개의 할로치환체를 갖는 C1-C5-알카노일; 벤조일, 페닐아세틸 또는 페닐프로피오닐, 또는 1내지 5개의 할로 또는 메틸 또는 1내지 2개의 메톡실, 니트로 또는 하이드록시 치환체를 갖는 벤조일, 페닐아세틸 또는 페닐프로피오닐이며, R3는 하이드록시 C1-C5-알카노일옥시 ; 1내지 3개의 할로 치환체를 갖는 C1-C5-알카노일옥시; 벤조일옥시, 페닐아세톡시 또는 페녹시아세톡시, 또는 1내지 5개의 할로 또는 메틸 또는 1내지 2개의 메톡실, 니트로 또는 하이드록실 치환체를 갖는 벤조일옥시, 페닐 아세톡시 또는 페녹시아세톡시 ; 또는이다.
- 임신한 암컷 반추동물의 유선염을 치료 또는 예방하기에 유용한 약제의 제조에 있어서의 틸미코신의 용도.
- 제1항 또는 제2항에 있어서, 상기 임신한 암컷 반추동물의 수유 반추동물이며, 투여 후에는 분만할 때까지 더 이상 착유하지 않고 유지시키는 용도.
- 제1항 내지 제3항중 어느 한항에 있어서, 상기 약제가 임신한 수유 반추동물에게 적어도 분만 25일 전에 투여하도록 고안된 용도.
- 제1항 또는 제2항에 있어서, 상기 약제가 분만경험이 없는 어린 암소에게 적어도 분만 25일 전에 투여하기에 적합한 용도.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69472091A | 1991-05-02 | 1991-05-02 | |
| US694,720 | 1991-05-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR920021142A true KR920021142A (ko) | 1992-12-18 |
Family
ID=24790008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019920007370A KR920021142A (ko) | 1991-05-02 | 1992-04-30 | 유선염 치료법 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0512779A1 (ko) |
| JP (1) | JPH05186355A (ko) |
| KR (1) | KR920021142A (ko) |
| CN (1) | CN1066269A (ko) |
| AU (1) | AU652443B2 (ko) |
| CA (1) | CA2067520A1 (ko) |
| CZ (1) | CZ133592A3 (ko) |
| IE (1) | IE921419A1 (ko) |
| IL (1) | IL101749A0 (ko) |
| MX (1) | MX9202034A (ko) |
| NO (1) | NO921720L (ko) |
| NZ (1) | NZ242557A (ko) |
| TW (1) | TW221028B (ko) |
| ZA (1) | ZA923125B (ko) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6605599B1 (en) | 1997-07-08 | 2003-08-12 | Bristol-Myers Squibb Company | Epothilone derivatives |
| US6608033B1 (en) | 1999-08-27 | 2003-08-19 | Pfizer Inc. | Treatment or prevention of coccidiosis |
| CN103923141B (zh) * | 2014-04-21 | 2016-04-27 | 西南大学 | 一种依托替米考星的合成方法 |
| CN106692137A (zh) * | 2016-12-27 | 2017-05-24 | 王�华 | 一种急性乳腺炎的乳导管治疗方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820695A (en) * | 1982-09-13 | 1989-04-11 | Eli Lilly And Company | C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics |
| FR2646081A1 (ko) * | 1989-04-20 | 1990-10-26 | Adir |
-
1992
- 1992-04-29 ZA ZA923125A patent/ZA923125B/xx unknown
- 1992-04-29 CA CA002067520A patent/CA2067520A1/en not_active Abandoned
- 1992-04-29 TW TW081103349A patent/TW221028B/zh active
- 1992-04-30 KR KR1019920007370A patent/KR920021142A/ko not_active Application Discontinuation
- 1992-04-30 NO NO92921720A patent/NO921720L/no unknown
- 1992-04-30 IL IL101749A patent/IL101749A0/xx unknown
- 1992-04-30 MX MX9202034A patent/MX9202034A/es unknown
- 1992-04-30 NZ NZ242557A patent/NZ242557A/en unknown
- 1992-04-30 CN CN92103134A patent/CN1066269A/zh active Pending
- 1992-04-30 CZ CS921335A patent/CZ133592A3/cs unknown
- 1992-04-30 AU AU15937/92A patent/AU652443B2/en not_active Expired - Fee Related
- 1992-05-01 JP JP4112525A patent/JPH05186355A/ja not_active Withdrawn
- 1992-05-01 EP EP92304005A patent/EP0512779A1/en not_active Ceased
- 1992-07-01 IE IE141992A patent/IE921419A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW221028B (ko) | 1994-02-11 |
| AU1593792A (en) | 1992-11-05 |
| IE921419A1 (en) | 1992-11-04 |
| CN1066269A (zh) | 1992-11-18 |
| AU652443B2 (en) | 1994-08-25 |
| JPH05186355A (ja) | 1993-07-27 |
| IL101749A0 (en) | 1992-12-30 |
| ZA923125B (en) | 1993-10-29 |
| EP0512779A1 (en) | 1992-11-11 |
| NZ242557A (en) | 1993-10-26 |
| CZ133592A3 (en) | 1993-01-13 |
| MX9202034A (es) | 1992-11-01 |
| NO921720L (no) | 1992-11-03 |
| NO921720D0 (no) | 1992-04-30 |
| CA2067520A1 (en) | 1992-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9084719B2 (en) | Compositions and method for treating infection in cattle and swine | |
| BR112019012861A2 (pt) | compostos para o tratamento de doença respiratória bovina ou suína | |
| KR920021142A (ko) | 유선염 치료법 | |
| US3692904A (en) | Method for treating scours in domestic livestock | |
| Dhaliwal et al. | Efficacy of prostaglandin F2-alpha administration for inducing estrus in buffalo | |
| KR940013500A (ko) | 수생 종의 그람-양성 질환 치료방법 | |
| JPS5489036A (en) | Remedy and preventive for hypersensitivity to light | |
| GB902659A (en) | A process for the production of a derivative of thebaine | |
| GB1287664A (en) | Epierythromycylamine and epierythromycyl b amine | |
| US2472453A (en) | Streptomycin composition of reduced toxicity | |
| WU | Gestational effect of allylestrenol | |
| KR940002268A (ko) | 21-클로로-프레그난 유도체 | |
| GB1137064A (en) | Veterinary pharmaceutical formulations and method of treatment of animals | |
| RU1801002C (ru) | Способ лечени респираторных болезней тел т | |
| Craft | Abortion: use of prostaglandins and epidural analgesia | |
| Thomas et al. | 1115 The 9-d CIDR-PG protocol: Incorporation of prostaglandin pretreatment into a long-term, CIDR-based estrus synchronization protocol improves timed AI pregnancy rates in postpartum suckled beef cows | |
| Viitanen et al. | Concentrations of metronidazole and tinidazole in abdominal tissues after a single intravenous infusion and repetitive oral administration | |
| US3251736A (en) | Methods of exterminating liver-fluke with salicylanilides | |
| JANCKE et al. | Clinical and experimental investigations with Sernyl and Combelen for immobilization of ruminants | |
| McLean et al. | The prevention of liver necrosis by alpha-tocopherol, methionine, and cysteine by oral and parenteral routes | |
| McGregor | A report on the value of two chemotherapeutic agents in the control of enterohepatitis (blackhead) in turkeys | |
| KR870010868A (ko) | 항 프로게스테론성 활성을 갖는 제약조성물 및 이들의 제조방법 | |
| Miyake et al. | 2α, 3α-Epithio-5α-Androstan-17β-yl 1-Methoxy Cyclopentyl Ether (10364-S), A New Orally Active Anabolic-Androgenic Steroid | |
| KR930000116A (ko) | 돼지 흉막 폐렴 예방/치료 조성물 | |
| KR890007737A (ko) | 진토작용을 하는 약제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |